These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 9346769

  • 1. Loss of serum HBsAg after interferon-A therapy in liver transplant patients with recurrent hepatitis-B infection.
    Ben-Ari Z, Shmueli D, Shapira Z, Mor E, Tur-Kaspa R.
    Liver Transpl Surg; 1997 Jul; 3(4):394-7. PubMed ID: 9346769
    [Abstract] [Full Text] [Related]

  • 2. Recurrence-free long-term survival after liver transplantation for hepatitis B using interferon-alpha pretransplant and hepatitis B immune globulin posttransplant.
    Tchervenkov JI, Tector AJ, Barkun JS, Sherker A, Forbes CD, Elias N, Cantarovich M, Cleland P, Metrakos P, Meakins JL.
    Ann Surg; 1997 Sep; 226(3):356-65; discussion 365-8. PubMed ID: 9339942
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. De novo and apparent de novo hepatitis B virus infection after liver transplantation.
    Roche B, Samuel D, Gigou M, Feray C, Virot V, Schmets L, David MF, Arulnaden JL, Bismuth A, Reynes M, Bismuth H.
    J Hepatol; 1997 Mar; 26(3):517-26. PubMed ID: 9075658
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A randomized, controlled trial of a 24-month course of interferon alfa 2b in patients with chronic hepatitis B who had hepatitis B virus DNA without hepatitis B e antigen in serum.
    Lampertico P, Del Ninno E, Manzin A, Donato MF, Rumi MG, Lunghi G, Morabito A, Clementi M, Colombo M.
    Hepatology; 1997 Dec; 26(6):1621-5. PubMed ID: 9398007
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Interferon-alpha 2b improves short-term survival in patients transplanted for chronic liver failure caused by hepatitis B.
    Hassanein T, Colantoni A, De Maria N, Van Thiel DH.
    J Viral Hepat; 1996 Nov; 3(6):333-40. PubMed ID: 8947886
    [Abstract] [Full Text] [Related]

  • 9. Prostaglandin E in the treatment of recurrent hepatitis B infection after orthotopic liver transplantation.
    Flowers M, Sherker A, Sinclair SB, Greig PD, Cameron R, Phillips MJ, Blendis L, Chung SW, Levy GA.
    Transplantation; 1994 Jul 27; 58(2):183-92. PubMed ID: 8042236
    [Abstract] [Full Text] [Related]

  • 10. A randomized, controlled trial of recombinant alpha-interferon therapy for chronic hepatitis B.
    Di Bisceglie AM, Fong TL, Fried MW, Swain MG, Baker B, Korenman J, Bergasa NV, Waggoner JG, Park Y, Hoofnagle JH.
    Am J Gastroenterol; 1993 Nov 27; 88(11):1887-92. PubMed ID: 8237937
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Impaired response to alpha interferon in patients with an inapparent hepatitis B and hepatitis C virus coinfection.
    Zignego AL, Fontana R, Puliti S, Barbagli S, Monti M, Careccia G, Giannelli F, Giannini C, Buzzelli G, Brunetto MR, Bonino F, Gentilini P.
    Arch Virol; 1997 Nov 27; 142(3):535-44. PubMed ID: 9349299
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Pretransplantation interferon treatment and recurrence of hepatitis B virus infection after liver transplantation for hepatitis B-related end-stage liver disease.
    Marcellin P, Samuel D, Areias J, Loriot MA, Arulnaden JL, Gigou M, David MF, Bismuth A, Reynes M, Bréchot C.
    Hepatology; 1994 Jan 27; 19(1):6-12. PubMed ID: 8276368
    [Abstract] [Full Text] [Related]

  • 18. Efficacy of granulocyte-macrophage colony-stimulating factor or lamivudine combination with recombinant interferon in non-responders to interferon in hepatitis B virus-related chronic liver disease patients.
    Guptan RC, Thakur V, Kazim SN, Sarin SK.
    J Gastroenterol Hepatol; 2002 Jul 27; 17(7):765-71. PubMed ID: 12121506
    [Abstract] [Full Text] [Related]

  • 19. Complete hepatitis B virus prophylaxis withdrawal in hepatitis B surface antigen-positive liver transplant recipients after longterm minimal immunosuppression.
    Lenci I, Baiocchi L, Tariciotti L, Di Paolo D, Milana M, Santopaolo F, Manzia TM, Toti L, Svicher V, Tisone G, Perno CF, Angelico M.
    Liver Transpl; 2016 Sep 27; 22(9):1205-13. PubMed ID: 27272189
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.